Dental amalgam (or "silver-colored filling") is a durable metal alloy comprised of silver, copper and tin, in addition to mercury, which binds these components into a hard, stable substance. It has been used to safely restore the teeth of more than 100 million Americans.
Dental amalgam has an established record of safety and effectiveness, which the scientific community has extensively reviewed and affirmed. Moreover, the ADA encourages dental offices to follow its Best Management Practices for Amalgam Waste, which will help reduce discharges of used amalgam into dental office wastewater.Return to Top
Letters and Testimony
- December 15, 2010—ADA testimony delivered by Drs. Rod Mackert and Jon Knapp to FDA panel examining the science behind the agency's 2009 rule on dental amalgam.
- December 14, 2010—ADA statement to FDA panel examining the science behind the agency's 2009 rule on dental amalgam
- August 11, 2010—Letter to the State Department regarding a possible mercury control treaty.
- June 14, 2010—Statement on the FDA's decision to convene another advisory panel to reexamine the safety of dental amalgam.
- May 26, 2010—Testimony of William J. Walsh to the House Committee on Oversight and Government Reform's Domestic Policy Subcommittee, on the memorandum of understanding ("MOU") with the Environmental Protection Agency (EPA) and the National Association of Clean Water Agencies (NACWA).
- April 4, 2010—Letter sharing scientific information with EPA on potential releases ofmercury from amalgam-related sources into the environment
- February 25, 2010—Statement supporting the FDI World Dental Federation's 2009 "Resolution on Dental Amalgam."
- February 24, 2010—Letter urging members of the House to oppose H.R. 4615, the Consumers Have Options for Molar Protection Act. (PDF)
- September 15, 2009—Letter urging members of Congress to oppose H. Res. 648 on the grounds that it contains false and misleading statements about the toxicity of dental amalgam. (PDF)
- August 12, 2009—Letter commending the FDA for allowing credible, peer-reviewed science to guide its final rule categorizing encapsulated dental amalgam as a Class II medical device. (PDF)
- July 28, 2009—Statement on the U.S. Food and Drug Administration's decision not to place any restriction on the use of encapsulated dental amalgam.
- June 23, 2009—Letter commending the Environmental Protection Agency for its ongoing efforts to help promote the Association’s Best Management Practices for Amalgam Waste. (PDF)
- July 28, 2008—Comments on the FDA’s proposal to reclassify encapsulated dental amalgam and dental mercury as Class II devices and add special packaging and labeling controls for amalgam alloy. (PDF)
- July 8, 2008—Testimony of William J. Walsh to the House Committee on Oversight and Government Reform's Domestic Policy Subcommittee, on voluntary efforts to limit the environmental impact of dental amalgam. (PDF)
- December 21, 2007—Comments on the EPA's proposals to study an amalgam pretreatment requirement for dental offices. (PDF/1MB)
- November 14, 2007—Testimony to the House Committee on Oversight and Government Reform's Domestic Policy Subcommittee, on the regulation of dental amalgam and its impact on the environment. (PDF)
- October 25, 2007—Comments by the ADA, et al., on the draft Mercury in Products Phase-Down Strategy. (PDF)
- September 7, 2006—Testimony of Dr. Milton V. Marshall to the Food and Drug Administration (FDA’s) Dental Products Advisory Panel, supporting the safety of dental amalgam. (PDF)
- September 6, 2006—Testimony of Dr. Amid Ismail to the Food and Drug Administration (FDA’s) Dental Products Advisory Panel, supporting the safety of dental amalgam. (PDF)
- September 6, 2006—Testimony of Dr. Ronald R. Zentz to the Food and Drug Administration (FDA’s) Dental Products Advisory Panel, supporting the safety of dental amalgam. (PDF)
- ADA Positions, Policies & Statements
- Best Management Practices for Amalgam Waste
- Press Kit: Dental Fillings
- Amalgam (Dental Filling Options)
- Amalgam Separators
Additional ResourcesReturn to Top
For additional information, please contact:
1111 14th Street NW, Suite 1100
Washington, DC 20005
State Government Affairs
ADA Chicago Headquarters
211 East Chicago Avenue
Chicago, IL 60611